Dr. Buchanan will helm Belharra's research organization as the company progresses its lead immunology and oncology programs, advances activities with its pharma collaborators, and enriches its ...

Alloy Therapeutics ("Alloy"), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...

A new era, where AI is at the centre of the drug discovery process is emerging, says Charlotte Deane, a professor of ...

UK Biobank's proteomics study will measure 5,400 proteins in 600,000 samples, tracking changes over mid-to-late life. By ...

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...

Our fair value estimate for WuXi is HKD 24.60 per share. WuXi has been growing at a CAGR of 53.3% for the past eight years. Although its USD 20.5 billion total backlog revenue supports our growth ...

Light Horse’s CEO said the biotech’s initial focus will be on “high-value and historically challenging” oncology targets.

The global biotechnology industry market size is projected to expand from USD 483.0 billion in 2024 to USD 546.0 billion by ...

With the intensification of global population aging, muscle atrophy, characterized by the loss of muscle mass and function, ...

Scientists have long considered ketones (a fundamental chemical class) and esters (molecules formed when an acid reacts with ...

By mid-2025, the biotech will split into two entities: a new, as-yet-unnamed innovative medicines specialist and a cell ...

Large language models may unlock a new and valuable type of research.